Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+2.87M
-
Total reported value, excl. options
-
$80.7M
-
Value change
-
+$8.34M
-
Put/Call ratio
-
0
-
Number of buys
-
21
-
Number of sells
-
-21
-
Price
-
$2.97
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2014
65 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2014.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 123M outstanding shares and own 22.04% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (6.72M shares), Point72 Asset Management, L.P. (3.5M shares), FRANKLIN RESOURCES INC (2.51M shares), Broadfin Capital, LLC (2.4M shares), VANGUARD GROUP INC (1.95M shares), FEDERATED INVESTORS INC /PA/ (1.44M shares), SPHERA FUNDS MANAGEMENT LTD. (1.06M shares), Opaleye Management Inc. (975K shares), Catalyst Capital Advisors LLC (955K shares), and Private Capital Advisors, Inc. (827K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.